Please login to the form below

Not currently logged in
Email:
Password:

Cardinal Health hires new executive VP of strategy and corporate development

US-based drug delivery and healthcare company Cardinal Health hires Mr Vivek Jain as executive vice-president of strategy and corporate development

US-based drug delivery and healthcare company Cardinal Health has hired Mr Vivek Jain as executive vice-president of strategy and corporate development.

Jain will be responsible for long-range planning and mergers and acquisitions that complement the company's organic growth goals. He will report to R Kerry Clark, Cardinal Health's CEO.

Jain will join Cardinal Health on 20 August 2007. He previously served as senior vice-president at Philips Medical Systems. He replaces Brendan Ford, who is retiring from the company after 16 years in the legal and corporate development functions.

Jain is a 13-year veteran of the health-care industry with a broad range of strategic planning and merger experience for pharmaceutical and medical device companies. Prior to Philips, he was an investment banker at JP Morgan Securities or its predecessor companies for more than a decade. In 2002, he was named co-head of the global health-care investment banking group and has been primarily focused on the pharmaceutical, medical device and diagnostics sectors for his entire career.

14th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics